HempFusion Wellness Inc. CBDHF Archives - Page 4 of 4

ThursdayMar 25, 2021 1:14 pm

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Announces Completion of Pilot Trial, Releases White Paper

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has completed a pilot study assessing the effect of its HempFusion formulation CBD Capsules(R) (HempFusion 20mg CBD capsules with botanical terpenes) as it relates to a combination of anti-inflammatories in lowering the results of the chronic inflammation test. The study was conducted in collaboration with Kansas-based Inflammatory Markers Laboratory (“IML”). In addition, the company also released a white paper titled, “Oral Formulation May Modulate Thromboxane Production.” The white paper was s co-authored by IML director Gordon Ens and…

TuesdayMar 23, 2021 1:47 pm

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Announces Results from CBD Liver Safety Study Have Been Released

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has announced that Validcare released its initial findings from an industry-sponsored, decentralized, human-safety study of hemp-derived CBD products. Validcare is coordinating the execution of the study, which HempFusion was involved with. The study may be the largest human observational, liver and human toxicology study to date. According to HempFusion’s announcement, the seven-month-long study showed no evidence of liver toxicity in any of the 839 participants enrolled in the clinical trials; the company noted that the study results are…

MondayMar 22, 2021 1:33 pm

HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 800) Enters China with Probulin Probiotics

HempFusion Wellness Inc. has announced the launch of certain Probulin Probiotics products in China to be sold on Alibaba Group Holding’s Tmall Global Tmall offers a number of features and advantages, which will be pivotal in helping HempFusion earn significant revenue Probulin Probiotics is recognized as one of the fastest-growing probiotics brands in the United State Natural Products Industry, according to SPINS syndicated data, and by entering the Chinese market, HempFusion hopes to replicate this growth in the vast Chinese marketplace The Chinese probiotics market is booming and is expected to reach $12.75 billion in 2022, up from $6.47 billion…

ThursdayMar 18, 2021 10:36 am

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Launches Probulin Probiotics in China Through World’s Largest Cross-Border Marketplace

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, through its wholly owned subsidiary Probulin Probiotics LLC, is offering products in China. The products are available on Alibaba Group Holding’s Tmall (“Tmall”) Global, the world’s largest cross-border online marketplace, with a reach of more than 750 million potential customers in China, Hong Kong, Macau and Taiwan. Calling the move a tremendous opportunity, the company plans to begin shipping product next week, with products available for purchase beginning March 29, 2021. The company anticipates having its Total Care…

TuesdayMar 09, 2021 10:02 am

QualityStocksNewsBreaks – HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Ranks as Top Performer at Major Food-Drug Mass Retailer

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, announced that according to a recent NielsenIQ report, its OTC topical products were ranked number-one in both sales dollars and units sold at a major Food & Drug Mass (“FDM”) retailer. The FDM channel is the largest sales opportunity for HempFusion’s products as 41% of CBD consumers have recently started shopping in-store again for products that contain CBD, according to a recent study. Those numbers were supported as CBD specialty retailers and pharmacies saw an uptick in consumer-reported purchasing.…

WednesdayMar 03, 2021 11:36 am

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Announces Submission of Novel Foods Application to UK’s FSA

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has submitted its dossier to the United Kingdom's Regulatory Food Safety Agency ("FSA"). HempFusion made the application in conjunction with its strategic and exclusive supply chain partner. The company has now taken the first step in the approval process to obtain approval for products that contain CBD to be sold retail in the UK. The submission requires a detailed analysis of the quality, stability and safety of HempFusion's raw ingredients as well as other unique product formulations. The…

FridayFeb 26, 2021 10:37 am

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Common Shares Approved for DTC Full Service

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has announced that the Depository Trust Company ("DTC") has approved its common shares for DTC full-service eligibility. The approval is for the United States and means that the common shares can now be both traded and serviced through DTC's electronic book-entry system. A subsidiary of the Depository Trust & Clearing Corp. ("DTCC"), DTC provides clearing and settlement services for the financial markets; the entity also settles securities transactions in the United States. By utilizing this electronic method of…

WednesdayFeb 17, 2021 10:07 am

QualityStocksNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) to Supply HempFusion CBD for Potentially Groundbreaking Research at Mount Sinai Medical Hospital

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has announced that Mount Sinai Medical Hospital, New York City, has selected HempFusion CBD as the exclusive brand and the sole supplier in a six-month clinical trial. Dr. David Harnick, a board-certified cardiologist and electrophysiologist and assistant professor in medicine and cardiology at Mount Sinai, is conducting the trial comprised of two studies that is one of the first of its kind in the area of CBD’s effect on targeted cardiology markers. “Studying the potential effects that CBD…

Site Search

Company Search

Tag: HempFusion Wellness Inc. CBDHF